Daniel D. Buchanan

23.1k citations

181 papers · 6.2k indexed · h-index 45

Impact in

Pathology and Forensic Medicine top 0.2%
- Genetic factors in colorectal cancer
Oncology top 0.5%
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Treatments and Studies

Papers in ⓘ

Pathology and Forensic Medicine 114
- Genetic factors in colorectal cancer 113
Cancer Research 51
- Cancer Genomics and Diagnostics 45

Co-authors: Joanne Young (42 shared papers)Mark A. Jenkins (83 shared papers)John L. Hopper (63 shared papers)Aung Ko Win (55 shared papers)Polly A. Newcomb (38 shared papers)Christophe Rosty (43 shared papers)Mark Clendenning (46 shared papers)John A. Baron (18 shared papers)
Journals: Familial Cancer (13 papers)Cancer Epidemiology Biomarkers & Prevention (12 papers)International Journal of Cancer (9 papers)Cancer Research (5 papers)Gastroenterology (4 papers)
Partner nations: Australia United States Canada

In The Last Decade

Daniel D. Buchanan

173 papers receiving 6.1k citations

Peers

Countries citing papers authored by Daniel D. Buchanan

Since Specialization

Citations

This map shows the geographic impact of Daniel D. Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel D. Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel D. Buchanan more than expected).

Fields of papers citing papers by Daniel D. Buchanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel D. Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel D. Buchanan. The network helps show where Daniel D. Buchanan may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel D. Buchanan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel D. Buchanan Line = papers co-authored together Daniel D. Buchanan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 181 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival Gastroenterology ·Amanda I. Phipps, Paul J. Limburg, John A. Baron, Andrea N. Burnett‐Hartman, Daniel J. Weisenberger, Peter W. Laird, Frank A. Sinicrope, Christophe Rosty, Daniel D. Buchanan, John D. Potter, Polly A. Newcomb	2014	298
2	Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer Cancer Research ·Dmitri Mouradov, Clare Sloggett, Robert N. Jorissen, Christopher G. Love, Shan Li, Antony W. Burgess, Diego Arango, Robert L. Strausberg, Daniel D. Buchanan, Samuel Wormald, Liam O’Connor, Jennifer L. Wilding, David Bicknell, Ian Tomlinson, Walter F. Bodmer, John M. Mariadason, Oliver M. Sieber	2014	287
3	Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification Journal of Medical Genetics ·Michael T. Parsons, Daniel D. Buchanan, Bryony A. Thompson, Joanne Young, Amanda B. Spurdle	2012	215
4	Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancer Histopathology ·Jeremy R. Jass, Kristi Baker, Inti Zlobec, Tetsuro Higuchi, Melissa Barker, Daniel D. Buchanan, Joanne Young	2006	198
5	KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers British Journal of Cancer ·Amanda I. Phipps, Daniel D. Buchanan, Karen W. Makar, Aung Ko Win, John A. Baron, Noralane M. Lindor, John D. Potter, Polly A. Newcomb	2013	192
6	Molecular Characterization of MSI-H Colorectal Cancer by MLHI Promoter Methylation, Immunohistochemistry, and Mismatch Repair Germline Mutation Screening Cancer Epidemiology Biomarkers & Prevention ·Jenny N. Poynter, Kimberly D. Siegmund, Daniel J. Weisenberger, Tiffany I. Long, Stephen N. Thibodeau, Noralane M. Lindor, Joanne Young, Mark A. Jenkins, John L. Hopper, John A. Baron, Daniel D. Buchanan, Graham Casey, A. Joan Levine, Loı̈c Le Marchand, Steven Gallinger, Bharati Bapat, John D. Potter, Polly A. Newcomb, Robert W. Haile, Peter W. Laird, (unknown)	2008	179
7	GSK3B polymorphisms alter transcription and splicing in Parkinson's disease Annals of Neurology ·John B. Kwok, Marianne Hallupp, Clement T. Loy, Daniel Kam Yin Chan, Jean Woo, George D. Mellick, Daniel D. Buchanan, Peter A. Silburn, Glenda M. Halliday, Peter R. Schofield	2005	176
8	Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study Annals of Oncology ·Rodrigo Dienstmann, Mike J. Mason, Frank A. Sinicrope, Amanda I. Phipps, Sabine Tejpar, Arild Nesbakken, Stine A. Danielsen, Anita Sveen, Daniel D. Buchanan, Mark Clendenning, Christophe Rosty, Brian M. Bot, Steven R. Alberts, J. Milburn Jessup, Ragnhild A. Lothe, Mauro Delorenzi, Polly A. Newcomb, Daniel J. Sargent, Justin Guinney	2017	166
9	DNA methylation‐based biological aging and cancer risk and survival: Pooled analysis of seven prospective studies International Journal of Cancer ·Pierre‐Antoine Dugué, Julie K. Bassett, Jihoon E. Joo, Chol‐Hee Jung, Ee Ming Wong, Margarita Moreno‐Betancur, Daniel F. Schmidt, Enes Makalic, Shuai Li, Gianluca Severi, Allison Hodge, Daniel D. Buchanan, Dallas R. English, John L. Hopper, Melissa C. Southey, Graham G. Giles, Roger L. Milne	2017	137
10	Tau haplotypes regulate transcription and are associated with Parkinson's disease Annals of Neurology ·John B. Kwok, Erdahl Teber, Clement T. Loy, Marianne Hallupp, Garth A. Nicholson, George D. Mellick, Daniel D. Buchanan, Peter A. Silburn, Peter R. Schofield	2004	128
11	Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features Modern Pathology ·Christophe Rosty, Joanne Young, Michael D. Walsh, Mark Clendenning, Rhiannon Walters, Sally‐Ann Pearson, Erika Pavluk, Belinda Nagler, David Pakenas, Jeremy R. Jass, Mark A. Jenkins, Aung Ko Win, Melissa C. Southey, Susan Parry, John L. Hopper, Graham G. Giles, Elizabeth Williamson, Dallas R. English, Daniel D. Buchanan	2013	126
12	Hyperplastic Polyposis Syndrome: Phenotypic Presentations and the Role of MBD4 and MYH Gastroenterology ·Elizabeth Chow, Lara Lipton, Elly Lynch, Rebecca D’Souza, C. Aragona, L Hodgkin, Gregor J. Brown, Ingrid Winship, Melissa Barker, Daniel D. Buchanan, Shannon Cowie, Steve Nasioulas, Desirée du Sart, Joanne Young, Barbara Leggett, Jeremy R. Jass, Finlay Macrae	2006	124
13	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype Modern Pathology ·Michael D. Walsh, Mark Clendenning, Elizabeth Williamson, Sally‐Ann Pearson, Rhiannon Walters, Belinda Nagler, David Packenas, Aung Ko Win, John L. Hopper, Mark A. Jenkins, Andrew Haydon, Christophe Rosty, Dallas R. English, Graham G. Giles, Michael A. McGuckin, Joanne Young, Daniel D. Buchanan	2013	122
14	Quality Assessment and Correlation of Microsatellite Instability and Immunohistochemical Markers among Population- and Clinic-Based Colorectal Tumors Journal of Molecular Diagnostics ·Mine Cicek, Noralane M. Lindor, Steven Gallinger, Bharati Bapat, John L. Hopper, Mark A. Jenkins, Joanne Young, Daniel D. Buchanan, Michael D. Walsh, Loı̈c Le Marchand, Terrilea Burnett, Polly A. Newcomb, William M. Grady, Robert W. Haile, Graham Casey, Sarah J. Plummer, Lisa A. Krumroy, John A. Baron, Stephen N. Thibodeau	2011	113
15	PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival PLoS ONE ·Christophe Rosty, Joanne Young, Michael D. Walsh, Mark Clendenning, Kristy Sanderson, Rhiannon Walters, Susan Parry, Mark A. Jenkins, Aung Ko Win, Melissa C. Southey, John L. Hopper, Graham G. Giles, Elizabeth Williamson, Dallas R. English, Daniel D. Buchanan	2013	105
16	BRAFV600E Immunohistochemistry Facilitates Universal Screening of Colorectal Cancers for Lynch Syndrome The American Journal of Surgical Pathology ·Christopher W. Toon, Michael D. Walsh, Angela Chou, David Capper, Adele Clarkson, Loretta Sioson, Stephen Clarke, Scott Mead, Rhiannon Walters, Mark Clendenning, Christophe Rosty, Joanne Young, Aung Ko Win, John L. Hopper, Ashley Crook, Andreas von Deimling, Mark A. Jenkins, Daniel D. Buchanan, Anthony J. Gill	2013	104
17	The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial Annals of Oncology ·Jennifer Mooi, Pratyaksha Wirapati, Rebecca Asher, Chee Khoon Lee, Peter Savas, Timothy Price, Amanda Townsend, Jennifer E. Hardingham, Daniel D. Buchanan, David S. Williams, Sabine Tejpar, John M. Mariadason, Niall C. Tebbutt	2018	99
18	BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics Cancer Epidemiology Biomarkers & Prevention ·Amanda I. Phipps, Daniel D. Buchanan, Karen W. Makar, Andrea N. Burnett‐Hartman, Anna E. Coghill, Michael N. Passarelli, John A. Baron, Dennis J. Ahnen, Aung Ko Win, John D. Potter, Polly A. Newcomb	2012	97
19	Association of DNA Methylation-Based Biological Age With Health Risk Factors and Overall and Cause-Specific Mortality American Journal of Epidemiology ·Pierre‐Antoine Dugué, Julie K. Bassett, Jihoon E. Joo, Laura Baglietto, Chol-Hee Jung, Ee Ming Wong, Giovanni Fiorito, Daniel F. Schmidt, Enes Makalic, Shuai Li, Margarita Moreno‐Betancur, Daniel D. Buchanan, Paolo Vineis, Dallas R. English, John L. Hopper, Gianluca Severi, Melissa C. Southey, Graham G. Giles, Roger L. Milne	2017	95
20	Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer Clinical Gastroenterology and Hepatology ·Joanne Young, Melissa Barker, Lisa A. Simms, Michael Walsh, K. G. Biden, Daniel D. Buchanan, Ron Buttenshaw, Vicki Whitehall, Shanna A. Arnold, L JACKSON, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2005	90

About Daniel D. Buchanan

Daniel D. Buchanan is a scholar working on Pathology and Forensic Medicine, Cancer Research, Oncology, Neurology and Genetics, having authored 181 papers that have together received 6.2k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (113 papers), Colorectal Cancer Screening and Detection (68 papers), Cancer Genomics and Diagnostics (45 papers), Colorectal Cancer Treatments and Studies (32 papers), Epigenetics and DNA Methylation (21 papers), Parkinson's Disease Mechanisms and Treatments (12 papers), Multiple and Secondary Primary Cancers (7 papers) and Gastric Cancer Management and Outcomes (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.1k citations), Oncology (3.0k citations), Cancer Research (1.5k citations), Molecular Biology (2.0k citations) and Neurology (371 citations). Daniel D. Buchanan has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Joanne Young, Mark A. Jenkins, John L. Hopper, Aung Ko Win, Polly A. Newcomb, Christophe Rosty, Mark Clendenning, John A. Baron, John D. Potter and Amanda B. Spurdle. Their work appears in journals such as Familial Cancer, Cancer Epidemiology Biomarkers & Prevention, International Journal of Cancer, Cancer Research and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact